IRIS Accounts Production v25.1.4.42 08818432 director 1.4.24 31.3.25 31.3.25 Medium entities operating care homes. true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088184322024-03-31088184322025-03-31088184322024-04-012025-03-31088184322023-03-31088184322023-04-012024-03-31088184322024-03-3108818432ns15:EnglandWales2024-04-012025-03-3108818432ns14:PoundSterling2024-04-012025-03-3108818432ns10:Director12024-04-012025-03-3108818432ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3108818432ns10:MediumEntities2024-04-012025-03-3108818432ns10:Audited2024-04-012025-03-3108818432ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3108818432ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-3108818432ns10:FullAccounts2024-04-012025-03-3108818432ns10:OrdinaryShareClass12024-04-012025-03-3108818432ns10:RegisteredOffice2024-04-012025-03-3108818432ns5:RetainedEarningsAccumulatedLosses2024-03-3108818432ns5:RetainedEarningsAccumulatedLosses2023-03-3108818432ns5:RetainedEarningsAccumulatedLosses2025-03-3108818432ns5:RetainedEarningsAccumulatedLosses2024-03-3108818432ns5:CurrentFinancialInstruments2025-03-3108818432ns5:CurrentFinancialInstruments2024-03-3108818432ns5:Non-currentFinancialInstruments2025-03-3108818432ns5:Non-currentFinancialInstruments2024-03-3108818432ns5:ShareCapital2025-03-3108818432ns5:ShareCapital2024-03-310881843212024-04-012025-03-3108818432ns5:PlantMachinery2024-04-012025-03-3108818432ns5:FurnitureFittings2024-04-012025-03-3108818432ns5:ComputerEquipment2024-04-012025-03-3108818432ns5:ReportableOperatingSegment12024-04-012025-03-3108818432ns5:ReportableOperatingSegment12023-04-012024-03-3108818432ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2024-04-012025-03-3108818432ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-04-012024-03-3108818432ns15:UnitedKingdom2024-04-012025-03-3108818432ns15:UnitedKingdom2023-04-012024-03-3108818432ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2024-04-012025-03-3108818432ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-04-012024-03-3108818432ns5:OwnedAssets2024-04-012025-03-3108818432ns5:OwnedAssets2023-04-012024-03-310881843222024-04-012025-03-310881843222023-04-012024-03-3108818432ns5:LandBuildings2024-03-3108818432ns5:LongLeaseholdAssetsns5:LandBuildings2024-03-3108818432ns5:PlantMachinery2024-03-3108818432ns5:LandBuildings2024-04-012025-03-3108818432ns5:LongLeaseholdAssetsns5:LandBuildings2024-04-012025-03-3108818432ns5:LandBuildings2025-03-3108818432ns5:LongLeaseholdAssetsns5:LandBuildings2025-03-3108818432ns5:PlantMachinery2025-03-3108818432ns5:LandBuildings2024-03-3108818432ns5:LongLeaseholdAssetsns5:LandBuildings2024-03-3108818432ns5:PlantMachinery2024-03-3108818432ns5:FurnitureFittings2024-03-3108818432ns5:MotorVehicles2024-03-3108818432ns5:ComputerEquipment2024-03-3108818432ns5:MotorVehicles2024-04-012025-03-3108818432ns5:FurnitureFittings2025-03-3108818432ns5:MotorVehicles2025-03-3108818432ns5:ComputerEquipment2025-03-3108818432ns5:FurnitureFittings2024-03-3108818432ns5:MotorVehicles2024-03-3108818432ns5:ComputerEquipment2024-03-3108818432ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108818432ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108818432ns10:OrdinaryShareClass12025-03-3108818432ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31
REGISTERED NUMBER: 08818432 (England and Wales)











STRATEGIC REPORT,

REPORT OF THE DIRECTOR AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

ASPREY HEALTHCARE LIMITED

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Strategic Report 2

Report of the Director 4

Report of the Independent Auditors 5

Statement of Income and Retained Earnings 8

Balance Sheet 9

Cash Flow Statement 10

Notes to the Cash Flow Statement 11

Notes to the Financial Statements 13


ASPREY HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: P M Connell





REGISTERED OFFICE: Smallbrook Care Home
Suffolk Close
Horley
Suffolk
RH6 7DU





REGISTERED NUMBER: 08818432 (England and Wales)





AUDITORS: GBJ Financial Limited
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH1 6RW

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025


The director presents his strategic report for the year ended 31 March 2025.

REVIEW OF BUSINESS
The principal activity of the company continued to be that of operating care homes.

Turnover for the year has increased by 33.3% and gross profit margin has improved to 47.0% from 45.4% in 2023/24. Whilst overheads have risen slightly, finance costs have fallen noticeably from prior year levels. Overall, a net profit after tax of £650,203 (2024: net loss of £146,509) has been made.

PRINCIPAL RISKS AND UNCERTAINTIES
The director and Financial Controller constantly monitor the risks and uncertainties facing the company with particular reference to the exposure on cashflow liquidity, staffing, interest rates and credit risks. He is confident that there are suitable policies in place to mitigate these and there are no material risks and uncertainties which have not been considered in advance.

The company uses various financial instruments which include cash and other items, such as trade debtors and trade creditors and monitors liquidity issues that can arise directly from its operations. The main purpose of these financial instruments is to raise finance for the company's operations. The existence of these financial instruments exposes the company to a number of financial risks, which are described in more detail below.

The main risk arising from the company's financial instruments is liquidity risk. The director reviews and agrees policies for managing this risk which is summarised below. This policy has remained unchanged from previous years.

LIQUIDITY RISK
The company seeks to manage financial risk by ensuring sufficient liquidity is available to meet foreseeable needs and to invest cash into assets of the business prudently and ultimately for long-term profit. The company's policy throughout the year has been to achieve this objective through the day-to-day involvement of management teams in business decisions, rather than through setting maximum or minimum liquidity ratios.

MEASURING PERFORMANCE
The director uses a number of measures, both financial and non-financial to monitor and benchmark the performance of the company. He regards the following as the key financial indicators of performance.

- Sales maximization by managing average weekly room fee rates, to levellers that ultimately support operating profit - measuring the profits generated by the company's operations.

- Net cash flow from operating activities - measuring the performance in translating operating profit into cash flow through management of working capital.

The key non-financial indicators are associated with the company's ability to increase and maintain its occupancy rates.

FINANCIAL RESULTS
The results for the year and the financial position at the year-end were considered acceptable by the director who expects an increased rate of growth in the coming financial years.


ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

FUTURE PLANS
The director will continue to grow and develop the business in the future.

ON BEHALF OF THE BOARD:





P M Connell - Director


22 July 2025

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

REPORT OF THE DIRECTOR
FOR THE YEAR ENDED 31 MARCH 2025


The director presents his report with the financial statements of the company for the year ended 31 March 2025.

DIVIDENDS
No dividends will be distributed for the year ended 31 March 2025.

DIRECTOR
P M Connell held office during the whole of the period from 1 April 2024 to the date of this report.

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, GBJ Financial Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





P M Connell - Director


22 July 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ASPREY HEALTHCARE LIMITED


Opinion
We have audited the financial statements of Asprey Healthcare Limited (the 'company') for the year ended 31 March 2025 which comprise the Statement of Income and Retained Earnings, Balance Sheet, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information
The director is responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ASPREY HEALTHCARE LIMITED


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Director have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Director.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page four, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ASPREY HEALTHCARE LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities outlined above, to detect material misstatements in respect of irregularities, including fraud.

We evaluated management's incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls) and determined that the principal risks were related to posting inappropriate journal entries and management bias in accounting estimates. Audit procedures performed by the engagement team included:

- Discussions with management, including consideration of known or suspected instances of non-compliance with laws and regulations and fraud;
- Reviewing minutes of meetings between those charged with governance.
- Challenging assumptions and judgements made by management in determining their significant accounting estimates.
- Challenging why certain items are excluded or included from the underlying profit.
- Reviewing journal entries for appropriateness and to identify any unusual accounting entries.

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Jonathan Hillier (Senior Statutory Auditor)
for and on behalf of GBJ Financial Limited
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH1 6RW

22 July 2025

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £ £

TURNOVER 3 5,607,470 4,204,863

Cost of sales 2,969,360 2,296,258
GROSS PROFIT 2,638,110 1,908,605

Administrative expenses 1,085,089 999,416
OPERATING PROFIT 5 1,553,021 909,189

Interest receivable and similar income 332 1,937
1,553,353 911,126

Interest payable and similar expenses 6 903,150 1,057,635
PROFIT/(LOSS) BEFORE TAXATION 650,203 (146,509 )

Tax on profit/(loss) 7 - -
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR

650,203

(146,509

)

Retained earnings at beginning of year 1,421,107 1,567,616

RETAINED EARNINGS AT END OF
YEAR

2,071,310

1,421,107

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £ £ £
FIXED ASSETS
Tangible assets 8 13,393,740 13,372,935

CURRENT ASSETS
Debtors 9 154,591 154,582
Cash at bank and in hand 518 84,635
155,109 239,217
CREDITORS
Amounts falling due within one year 10 4,412,839 8,190,845
NET CURRENT LIABILITIES (4,257,730 ) (7,951,628 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

9,136,010

5,421,307

CREDITORS
Amounts falling due after more than one
year

11

7,064,500

4,000,000
NET ASSETS 2,071,510 1,421,307

CAPITAL AND RESERVES
Called up share capital 13 200 200
Retained earnings 14 2,071,310 1,421,107
SHAREHOLDERS' FUNDS 2,071,510 1,421,307

The financial statements were approved by the director and authorised for issue on 22 July 2025 and were signed by:





P M Connell - Director


ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £ £
Cash flows from operating activities
Cash generated from operations 1 1,529,242 787,144
Interest paid (903,150 ) (1,057,635 )
Tax paid - 58,501
Net cash from operating activities 626,092 (211,990 )

Cash flows from investing activities
Purchase of tangible fixed assets (99,971 ) (1,860,573 )
Interest received 332 1,937
Net cash from investing activities (99,639 ) (1,858,636 )

Cash flows from financing activities
New loans in year 3,250,000 -
Loan repayments in year (191,000 ) (112,500 )
Amount introduced by directors - 2,137,962
Amount withdrawn by directors (3,675,476 ) (1,000 )
Net cash from financing activities (616,476 ) 2,024,462

Decrease in cash and cash equivalents (90,023 ) (46,164 )
Cash and cash equivalents at
beginning of year

2

84,635

130,799

Cash and cash equivalents at end of
year

2

(5,388

)

84,635

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025


1. RECONCILIATION OF PROFIT/(LOSS) BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2025 2024
£ £
Profit/(loss) before taxation 650,203 (146,509 )
Depreciation charges 79,166 81,474
Finance costs 903,150 1,057,635
Finance income (332 ) (1,937 )
1,632,187 990,663
(Increase)/decrease in trade and other debtors (9 ) 16,141
Decrease in trade and other creditors (102,936 ) (219,660 )
Cash generated from operations 1,529,242 787,144

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2025
31.3.25 1.4.24
£ £
Cash and cash equivalents 518 84,635
Bank overdrafts (5,906 ) -
(5,388 ) 84,635
Year ended 31 March 2024
31.3.24 1.4.23
£ £
Cash and cash equivalents 84,635 130,799


ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.4.24 Cash flow At 31.3.25
£ £ £
Net cash
Cash at bank and in hand 84,635 (84,117 ) 518
Bank overdrafts - (5,906 ) (5,906 )
84,635 (90,023 ) (5,388 )
Debt
Debts falling due within 1 year (387,500 ) 5,500 (382,000 )
Debts falling due after 1 year (4,000,000 ) (3,064,500 ) (7,064,500 )
(4,387,500 ) (3,059,000 ) (7,446,500 )
Total (4,302,865 ) (3,149,023 ) (7,451,888 )

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Asprey Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates, and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period or in the period of the revision and future periods where the revision affects both current and future periods

Critical judgements: The following critical judgements (apart from those involving estimates)have had the most significant effect on amounts recognised in the financial statements.

Treatment of leases
Determine whether leases entered into by the company either as a lessor or a lease are operating leases or finance leases These decisions depend on an assessment of whether the risks and rewards of ownership have been transferred from the lessor to the lease on a lease by lease basis.

Tangible fixed assets
Tangible fixed assets, other than investment properties, are depreciated over their useful lives ing into account residual values, where appropriate. The actual lives of the assets and residual value are assessed annually and may vary depending upon a number of factors.

In reassessing asset lives, factors such as technological innovation, product life-cycle and maintenance programmes are taken into account. Residual value assessments consider issues such as future market conditions, the remaining life of the asset and projected disposal values. Regular reviews are carried out to determine whether there are indicators of impairment of the company's tangible fixed assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Computer equipment - 15% on reducing balance

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. TURNOVER

The turnover and profit (2024 - loss) before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2025 2024
£ £
Care home provision 5,607,470 4,204,863
5,607,470 4,204,863

An analysis of turnover by geographical market is given below:

2025 2024
£ £
United Kingdom 5,607,470 4,204,863
5,607,470 4,204,863

4. EMPLOYEES AND DIRECTORS
2025 2024
£ £
Wages and salaries 2,772,697 2,333,978
Social security costs 32,124 41,888
Other pension costs 49,809 39,601
2,854,630 2,415,467

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. EMPLOYEES AND DIRECTORS - continued

The average number of employees during the year was as follows:
2025 2024

Employees 88 80

2025 2024
£ £
Director's remuneration 138,158 138,840

5. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£ £
Depreciation - owned assets 79,166 81,474
Auditors' remuneration 6,694 5,967

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£ £
Bank loan interest 512,014 335,613
Directors loan interest 391,136 722,022
903,150 1,057,635

7. TAXATION

Analysis of the tax charge
No liability to UK corporation tax arose for the year ended 31 March 2025 nor for the year ended 31 March 2024.

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


8. TANGIBLE FIXED ASSETS
Freehold Long Plant and
property leasehold machinery
£ £ £
COST
At 1 April 2024 3,006,225 9,870,278 107,277
Additions - 62,536 822
At 31 March 2025 3,006,225 9,932,814 108,099
DEPRECIATION
At 1 April 2024 - - 64,460
Charge for year - - 6,401
At 31 March 2025 - - 70,861
NET BOOK VALUE
At 31 March 2025 3,006,225 9,932,814 37,238
At 31 March 2024 3,006,225 9,870,278 42,817

Fixtures
and Motor Computer
fittings vehicles equipment Totals
£ £ £ £
COST
At 1 April 2024 657,789 46,383 107,320 13,795,272
Additions 9,834 - 26,779 99,971
At 31 March 2025 667,623 46,383 134,099 13,895,243
DEPRECIATION
At 1 April 2024 314,744 9,002 34,131 422,337
Charge for year 50,442 9,124 13,199 79,166
At 31 March 2025 365,186 18,126 47,330 501,503
NET BOOK VALUE
At 31 March 2025 302,437 28,257 86,769 13,393,740
At 31 March 2024 343,045 37,381 73,189 13,372,935

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade debtors 122,916 129,512
Prepayments 31,675 25,070
154,591 154,582

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Bank loans and overdrafts (see note 12) 387,906 387,500
Trade creditors 50,558 107,191
Social security and other taxes 52,547 40,767
Other creditors 5,818 14,074
Directors' loan accounts 3,727,109 7,402,585
Accrued expenses 114,908 220,877
Deferred income 73,993 17,851
4,412,839 8,190,845

11. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£ £
Bank loans (see note 12) 7,064,500 4,000,000

12. LOANS

Bank borrowings are secured by fixed and floating charges over all the assets of the company including freehold and leasehold properties.

13. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £ £
200 Ordinary 1 200 200

ASPREY HEALTHCARE LIMITED (REGISTERED NUMBER: 08818432)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


14. RESERVES
Retained
earnings
£

At 1 April 2024 1,421,107
Profit for the year 650,203
At 31 March 2025 2,071,310

15. PENSION COMMITMENTS

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £49,809 (2024: £39,601). Contributions totalling £NIL (2024: £6,969) were payable to the fund at the balance sheet date and are included in creditors.

16. RELATED PARTY DISCLOSURES

During the year the company had an outstanding loan account with the director P M Connell. Debits totalling £3,675,476 (2024: £NIL) were made to the loan account. At the year end, the company owed P M Connell £3,727,109 (2024: £7,402,585).

17. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is P M Connell.